BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
DNMT1
,
Coagulation
,
Allergy to pollen
,
Lymphocyte
,
Personalized medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MAPK3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Amygdala
Caudate nucleus
Dorsal root ganglia
Globus pallidus
Thalamus lateral nuclei
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's…
Hot air injures human alveolar epithelial cells through ERK1/2 signaling-mediated ferroptosis.
Ferroptosis-related gene MAPK3 is associated with the neurological outcome after cardiac arrest.
ERK1/2 Inhibition Alleviates Diabetic Cardiomyopathy by Suppressing Fatty Acid Metabolism.
A first-in-class selective inhibitor of ERK1/2 and ERK5 overcomes drug resistance with a single-mole…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestin…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ